Cambridge, United Kingdom
CMS Ventures, launched in 2020, is the investment arm of China Medical System Holdings Limited (CMS), a well-established, innovation-driven specialty pharma founded in 1995, and listed on the Main Board of the Stock Exchange of Hong Kong Limited (stock code: 867). CMS Ventures receives supports from AstraZeneca and Cambridge Judge Business School. CMS Ventures provide patient capital for ambitious Biotech and Life Sciences start-ups in the 4Ds (Drugs, Devices, Diagnostics and Digital), interested in entering the Chinese market with a trusted partner of choice.
3
Total Investments
3
Portfolio Companies
-
Exits
1
Industries
General Information
Industries
Financial Services
Company Overview
About CMS Ventures
Recent Investments (3)
View All| Company | Stage | Amount | Date |
|---|---|---|---|
| Seed Round | •••••• | Mar 2024 | |
| Seed Round | •••••• | Oct 2022 | |
| Seed | •••••• | Sep 2021 |
All startup & investor data, one platform.
Filter investors by stage, sector, and geography. Compare portfolios side by side. Spot market signals before anyone else.
